The original ASPIRE™ trial, which focused on evaluating the safety and efficacy of ExaStim® in a clinical setting, completed ...

Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...

The FDA expanded the indication of eculizumab (Soliris) to include pediatric patients ages 6 and older with generalized ...

Sacral neuromodulation, in which electrical pulses from an implanted device help control the bladder, was found to ease symptoms in MS.

and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the publication of positive results from the investigator-sponsored Pathfinder2 Study in ...

Ten people aged between 21 and 68 with different levels of spinal cord injuries took part in the study, which has been published in the journal Neuromodulation: Technology At Neural Interface.

Ten people aged between 21 and 68 with different levels of spinal cord injuries took part in the study, which has been published in the journal Neuromodulation: Technology At Neural Interface. All ...

She recently received a type of spinal cord stimulation during a small clinical ... The results of the study were published in the journal Neuromodulation: Technology At Neural Interface.